Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate
about
Life extension in Drosophila by feeding a drug.Clinical and experimental applications of sodium phenylbutyrateCurrent and future pharmacological treatment strategies in X-linked adrenoleukodystrophyShort-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activationProgress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promiseEvidence that Chemical Chaperone 4-Phenylbutyric Acid Binds to Human Serum Albumin at Fatty Acid Binding SitesSynergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.Induction of human gamma globin gene expression by histone deacetylase inhibitorsInduction of fetal hemoglobin by propionic and butyric acid derivatives: correlations between chemical structure and potency of Hb F inductionButyrate increases the efficiency of translation of gamma-globin mRNA.ER stress dependent microparticles derived from smooth muscle cells promote endothelial dysfunction during thoracic aortic aneurysm and dissection.Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.Results from a Nationwide Cohort Temporary Utilization Authorization (ATU) survey of patients in france treated with Pheburane(®) (Sodium Phenylbutyrate) taste-masked granules.Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET.Enhancing cognition before clinical symptoms of dementia.Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo.Phenyl acyl acids attenuate the unfolded protein response in tunicamycin-treated neuroblastoma cellsReevaluating the hype: four bacterial metabolites under scrutiny.The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell miceFK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenitors.Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.4-PBA prevents pressure overload-induced myocardial hypertrophy and interstitial fibrosis by attenuating endoplasmic reticulum stressLiquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma.Identification of phenylbutyrate-generated metabolites in Huntington disease patients using parallel liquid chromatography/electrochemical array/mass spectrometry and off-line tandem mass spectrometry.Hydroxyurea for children with sickle cell diseaseAdeno-associated virus vector genomes persist as episomal chromatin in primate muscle.HIV-1 transcription and latency: an update.Inactivation of HDAC1 or HDAC2 induces gamma globin expression without altering cell cycle or proliferation.Eukaryotic initiation factor 2α phosphorylation mediates fetal hemoglobin induction through a post-transcriptional mechanismEvaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers.Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.The therapeutic potential of chemical chaperones in protein folding diseases.Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea.Neuroprotection by Endoplasmic Reticulum Stress-Induced HRD1 and Chaperones: Possible Therapeutic Targets for Alzheimer's and Parkinson's Disease.Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.Metabolite identification using a nanoelectrospray LC-EC-array-MS integrated system.
P2860
Q24530572-2DB7F5D3-52C6-42D2-BBB3-4100D12BC81EQ24613511-A1C932DC-6B50-4AE3-9E64-938A639395A2Q24618949-5D2DF1A2-FB48-4B12-83F0-DF286435CB4DQ28364488-053A911B-A462-4594-A657-A2315CE15D0BQ28393706-4C010742-6CCE-43C9-9696-829EA896F2DCQ28546608-42A05454-DE12-4018-8922-DAA9E6E4EB15Q33476165-2B1A9B4A-A302-412C-97F9-A87FE27D4A7CQ33598588-D6D10CAD-239C-408E-8B26-53FFBA0E5429Q33598612-C3320E69-24DF-4D71-8EC2-BA7BA5F5D7DFQ33677601-9A674649-9588-411F-B2CE-B86759C5C263Q33772309-3A5FCD7A-D43E-4F36-A137-F190FFB17E64Q33939797-BB1E6B08-547C-40D3-BD13-DB15FC358A10Q34207535-9DF96866-3902-4C5B-BBC0-1F6F04191CF3Q34349201-BB8BD9FD-1FAF-4276-AC47-28E9D1E0CBCEQ34361155-E6C6E1D6-DDFF-4C51-A2BB-928CDA1A32A1Q34708103-315D33F9-2BCA-47E2-919A-92F6CED868BEQ34723434-EA983620-6A29-49B9-B92C-6C66AB822D8BQ34723868-F58F620C-48C7-4CD0-A10C-52EB9E59127FQ34970563-8ECE5686-2534-4DAC-8044-A6468C7B885AQ35426826-4899B5C1-008E-43B6-9C89-6625BBC5CE67Q35859235-3AA3D7E6-5F35-4407-99FD-9190E2046796Q35986327-429ED199-05DE-45CF-A689-37220EF2E714Q36159085-38D1F9DC-DC63-4861-9C63-B8128DB9FFE2Q36414916-E1B0319E-3B68-460C-A390-9EC3ED11E415Q36478403-A8F118B2-8965-40FA-ADA6-09D57EE1C5AFQ36598779-68C9F8BD-E43A-424C-9553-304F988762A7Q36612962-4DC9D1D2-069E-4AE9-865B-6E1F219EBDD6Q36845715-AD954B0C-A27D-44DF-A4CF-940B07C61E5CQ36976156-09DEF16B-0A04-47F8-A09D-28C8A4F4FBC2Q37008748-26C25DFF-AD77-4112-BE9E-A9C755C486B8Q37046975-2F99AF3E-3233-4172-BA2C-D40A8E07A6EFQ37524864-8BAD96F7-18F7-4DB6-8C7C-E6AA723F1E77Q37644561-02CEE65B-66C2-4189-9846-AAFF62AE4C9CQ38139309-FB2ADDAB-D908-480E-9E1C-DC8C8EF80D73Q38211124-6CD8B794-40ED-4F5F-9C69-90A340822AB6Q42606424-1C242080-630E-48B5-8BC0-9EEBB48C6A79Q42705597-BAA1BE60-B1FE-46A6-8962-54B4CD0D5C8BQ42709676-7779AFF4-736B-47A2-ACF9-3A800C833E84Q43160990-CBBC81E4-AD78-40FD-A616-49B412922057
P2860
Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Induction of fetal hemoglobin ...... by oral sodium phenylbutyrate
@ast
Induction of fetal hemoglobin ...... by oral sodium phenylbutyrate
@en
Induction of fetal hemoglobin ...... by oral sodium phenylbutyrate
@nl
type
label
Induction of fetal hemoglobin ...... by oral sodium phenylbutyrate
@ast
Induction of fetal hemoglobin ...... by oral sodium phenylbutyrate
@en
Induction of fetal hemoglobin ...... by oral sodium phenylbutyrate
@nl
prefLabel
Induction of fetal hemoglobin ...... by oral sodium phenylbutyrate
@ast
Induction of fetal hemoglobin ...... by oral sodium phenylbutyrate
@en
Induction of fetal hemoglobin ...... by oral sodium phenylbutyrate
@nl
P2093
P1433
P1476
Induction of fetal hemoglobin ...... by oral sodium phenylbutyrate
@en
P2093
P304
P407
P577
1994-07-01T00:00:00Z